[1] 中华医学会感染病学分会, GRADE 中国中心. 中国乙型肝炎病毒母婴传播防治指南(2019 年版). 中华传染病杂志, 2019,37: 388-396.
[2] 崔富强, 庄辉. 我国新生儿乙型肝炎母婴阻断成就和展望.中国病毒病杂志, 2019, 9: 321-326.
[3] Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 2018, 67: 1560-1599.
[4] European Association for the Study of the Liver.EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol, 2017, 67: 370-398.
[5] Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J, Tita AT, et al. Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol, 2016, 214: 6-14.
[6] Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int, 2016, 10: 1-98.
[7] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015 更新版). 中华肝脏病杂志, 2015, 32:888-905.
[8] Peng S, Wan Z, Liu T, et al. Cesarean section reduces the risk of early mother-to-child transmission of hepatitis B virus. Dig Liver Dis, 2018, 50: 1076-1080.
[9] Chen HL, Cai JY, Song YP, et al. Vaginal delivery and HBV mother to child transmission risk after immunoprophylaxis: a systematic review and a meta-analysis. Midwifery, 2019, 74: 116-125.
[10] Westin J, Aleman S, Castedal M, et al. Management of hepatitis B virus infection, updated Swedish guidelines. Infect Dis (Lond), 2020, 52: 1-22.
[11] Arora A, Singh SP, Kumar A, et al. INASL position statements on prevention, diagnosis and management of hepatitis B virus infection in India: the Andaman statements. J Clin Exp Hepatol, 2018, 8:58-80.
[12] Chien RN, Kao JH, Peng CY, et al. Taiwan consensus statement on the management of chronic hepatitis B. J Formos Med Assoc, 2019, 118: 7-38. |
